Careers  |  Sign In  |  Register

Latest in Allergy & Clinical Immunology

CDC advisers have recommended that for children ages 2 to 10 at risk for invasive meningococcal disease, the quadrivalent conjugate vaccine Menactra is preferable to the polysaccharide vaccine Menomune. References and Resources Recommendation from the Advisory Committee on Immunization Practices...
The FDA has approved Zyrtec-D for nonprescription use in adults and children 12 years of age and older. References and Resources FDA Approves Nonprescription Zyrtec-D for Allergies Click Here to view announcement. Sponsored by The Doctor's...

Fails to alleviate moderate persistent asthma symptoms

Mepolizumab Fails in a Phase II Trial

Mepolizumab, an IL-5 inhibitor, failed to alleviate moderate persistent asthma symptoms in a phase II trial of patients resistant to corticosteroids. References and Resources Flood-Page P, Swenson C, Faiferman I. A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate...